leisure time -WSS

leisure time

author：fashion 2025-10-01 04:10:23 - browse：867

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： CDC recommends rationing of RSV shot due to shortages

WSS

Cassava reveals details — and problems — with Alzheimer's study

Why Sanofi got shellacked over its spinoff

Many immigrants are left out of maternal health programs

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Doctors increasingly discourage vaping amid mounting health concerns

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

leisure time

leisure time

focus

Novavax promises a turnaround & Lilly roils the obesity market

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

Hepatitis C has a cure — but many Americans still lack access to it

Emergency medicine has repudiated 'excited delirium.' Now what?

The high cost of giving birth even with insurance

Diversifying clinical trials isn't enough to close racial gaps: study

Jerome Adams on the need for new antivirals for Covid

Cassava reveals details — and problems — with Alzheimer's study

BioMarin wins approval for gene therapy to treat hemophilia A

Hospitals warn Medicare's drug payment fix is ‘unlawful’

leisure time

What AstraZeneca

HCA says smaller share of spending going to labor

Snowpack in the West is melting rapidly. Where will all that extra water go?

Paying for Covid pills will soon shift to insurers

Trump team launching legal defense fund to help pay legal bills

Paying for Covid pills will soon shift to insurers

focus

leisure time

hotspot

hotspot